Caitlyn Jordan Students and other members of the Notre Dame community attended Mass at the Basilica of the Sacred Heart on Wednesday night in memory of junior Theresa Sagartz who died last week.“As we situate Theresa’s death into the fabric of our day-to-day lives, we are invited to look back, not with sadness or regret, but with gratitude, to be thankful for the way she touched our hearts, both directly and indirectly [in] her love of her family and friends, the resilience with which she lived her life,” McCormick said.“Through Jesus’ life, death and resurrection, he demonstrated how far he would go to prove God’s love and lasting commitment to each of us. Jesus’ testimony and God’s desire to be in relationship with us now serves as the basis for our prayer tonight, to commend a sister, a daughter, a friend, a role model, back to God.”McCormick said Sagartz was a woman who lived selflessly and was known for both her compassion and leadership — evident in her multiple roles on campus, which included being an “honorary mom” to section 2A in Zahm House who brought oranges to soccer games.“The list could go on forever of the things that made Theresa, Theresa,” McCormick said. “But what we celebrate is her turning back to God, a God who so deeply loves each of us that he has created a space for us in him to return. Theresa’s life has changed. It has not ended.”Sagartz’s life was a manifestation of God’s grace, McCormick said.“God blessed Theresa with the precise amount of time needed for her to make an impact on this world. We no doubt would have preferred more of it, yet so goes the delicate and precious nature of life. And while we are tempted to measure the quality of life in years, the true measure of life is what you do in the time that you have,” McCormick said. “If a person with 75 years mostly wraps himself in anger and greed, what good is that? Is it somehow better than 21 years filled with love and service to others? … No matter the time we have here, five minutes or 100 years, we are invited to look forward, mirroring God’s love that extends beyond us and extends beyond death.”The fullness of Sagartz’s life can serve as inspiration, McCormick said.“Leaving the Basilica tonight, my sincere hope is that each of us might be changed in some way,” he said. “Perhaps we may express a deeper gratitude for the family, friends and those lives that we come in contact with on a daily basis. … Or maybe, we develop a deeper trust through Jesus’ life, death and resurrection — that we do not mourn Theresa’s death as if it were the end, but rather, prayerfully, as she begins her journey to eternal life.”Senior News Writer Catherine Owers contributed to this report.Tags: memorial, memorial mass, Student death, Theresa Sagartz Family, friends and members of the Notre Dame community filled the Basilica of the Sacred Heart Wednesday evening to honor the life of Theresa Sagartz, a junior and former resident of Pangborn Hall, who died last week in her off-campus apartment due to apparent natural causes related to a medical condition.University President Fr. John Jenkins celebrated the memorial Mass, and Fr. Pete McCormick, director of Campus Ministry, delivered the homily. The Notre Dame Liturgical Choir provided music for the Mass.
Aug 25, 2008 (CIDRAP News) – With influenza season well under way in the southern hemisphere, one of the three kinds of seasonal influenza virus is becoming increasingly resistant to the antiviral drug oseltamivir (Tamiflu), the World Health Organization (WHO) reported last week.Thirty-one percent (242 of 788) of influenza A/H1N1 isolates from 16 countries that were tested in recent months carried a mutation associated with oseltamivir resistance, the WHO said. In South Africa, all of the 107 isolates tested had this mutation, known as H274Y, the agency reported.Other countries and areas that tested 10 or more isolates and found resistance included Australia, 100% (10 of 10 isolates); Ghana, 20% (2 of 10) Hong Kong, 17% (97 of 583); and Chile, 13% (4 of 32 isolates).The findings strengthen a trend that that was first observed last January in Norway and subsequently in many other countries. Overall for the last quarter of 2007 and the first quarter of this year, 16% (1,182 of 7,528) of tested H1N1 isolates carried the resistance mutation, according to WHO figures. Resistance was found in 35 countries, mostly in the northern hemisphere, including in 12% of tested US isolates and 26% of tested Canadian isolates.”What we’re seeing is the evolution of the resistance gene and the distribution of it throughout the world,” said Lance Jennings, a clinical virologist with the Canterbury District Health Board in Christchurch, New Zealand, and chair of the Asia-Pacific Advisory Committee on Influenza, as quoted in an Aug 22 Bloomberg News report.In South Africa, Terry Besselaar, director of the National Influenza Centre in Johannesburg, said, “The patients are from across the country, so the resistant strain is widespread,” according to the Bloomberg report.The WHO said only 1 of the 107 patients in South Africa was taking oseltamivir, and no unusual clinical features or underlying conditions were found.No increase in oseltamivir resistance has been reported in the other two types of seasonal flu viruses, A/H3N2 and B. Recent WHO updates have not indicated which types are most common overall in the southern hemisphere this season, but the Aug 20 statement said flu was widespread in New Zealand, with H3 and B viruses predominant. The statement also cited sporadic flu activity in Argentina, with H1 viruses most common.Many countries have stockpiled oseltamivir, which is used to treat people infected with the H5N1 avian flu virus and is generally considered the most promising antiviral to use in case H5N1 evolves into a human pandemic strain. The WHO statement did not mention any reports of resistance to zanamivir (Relenza), the other drug in the neuraminidase inhibitor class.A spokeswoman for Roche, the maker of Tamiflu, said H5N1 viruses remain sensitive to the drug, according to the Bloomberg report. The spokeswoman, Claudia Schmitt, said the company plans to conduct surveillance on resistant and susceptible flu viruses during the 2008-09 flu season.In a summary of H1N1 resistance to oseltamivir in the the 2007-08 flu season, the WHO said in June that no link between “oseltamivir exposure and resistance at the individual patient level was noted.”The increasing oseltamivir resistance in H1N1 viruses has puzzled experts. In an editorial published by Eurosurveillance in January, authorities said resistant viruses with the H274Y mutation had been seen in previous flu seasons but were rare and did not spread easily. But the more recent H1N1 isolates with the mutation were “fitter” and were spreading in the community, they wrote.A recent update by the European Centre for Disease Prevention and Control (ECDC) observed, “At this stage the significance of these [resistance] findings remains uncertain. The emergence of drug resistance in the context of limited drug use is unexpected, and the extent of future circulation is difficult to predict.”See also: Jun 13 WHO statement on H1N1 oseltamivir resistance in 2007-08 seasonhttp://www.who.int/influenza/patient_care/antivirals/oseltamivir_summary/en/Feb 1 CIDRAP News story “Europe says Tamiflu-resistant virus seen in 9 countries”
Posted in mynutjobTagged: 2020年上海鸡店, 上海千花 女生自荐, 上海夜网VY, 上海夜网YZ, 夜上海论坛AD, 夜上海论坛AJ, 夜上海论坛FP, 夜上海论坛IC, 大成社区论坛, 爱上海OK, 爱上海QR, 爱上海ZO.